Recently, Cepheid (NASDAQ:CPHD) has received clearance from the US Food and Drug Administration (FDA) for its high-throughput automated molecular system GeneXpert Infinity-80. GeneXpert Infinity-80 is a latest addition in the GeneXpert System family of Cepheid and works on the GeneXpert module technology. The system was initially cleared in combination with the company’s Xpert Flu test and is scheduled to hit the market on July 1, 2012.
Similar to Cepheid’s current Infinity-48 system, this new … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here